Regenerative Medicine Challenges Hinder Their Development and Use: GAO

Regenerative medicine technologies, including CAR-T cell and stem cell therapies, are highly promising medical advancements but are being held back by the lack of widely accepted standards and guidelines to govern their use, development and manufacture, finds a report by the U.S. Government Accountability Office released Thursday.